Value Communications

In 2004, I joined a meeting at GSK about designing a clinical trial to include outcomes that could be used to gain reimbursement, which was a new thing at the time. When I went freelance, a health economics agency hired me to write a global value dossier – the agency was all about economic modelling and evidence generation, with writing seen as a side-line. That’s changed now that value comms is a thing.

Research, analysis, and writing

I have provided research, analysis, and writing support on global value dossiers (GVD), target product profile dossiers (TPP), burden, economics, costs, and treatment reviews (BECT), objection handlers, health technology assessments (HTA), insights advisory boards and market access workshops, and value comms manuals and slide-sets.

As well as contributing to many market access projects, I've written several complete draft dossiers:

Restless legs syndrome (GVD)
Alzheimer’s (GVD)
Chronic kidney disease (TPP)
Type 2 diabetes (BECT)
Vertigo (GVD)
Hypertension (BECT)
Transitional cell cancer of the ureter (HTA)
Prostate cancer (TPP)
Schizophrenia (GVD)
Irritable bowel syndrome (GVD)
Chronic kidney disease (GVD)
Haemophilia (GVD)

Global value dossiers

A GVD is the same as writing several reviews one after the other, then writing a review to explain the reviews, and then writing a list of propositions that cover each review in a few sentences.

A lot can go wrong with a GVD.

Selling a GVD:

Consistent, impactful, evidence-based, comprehensive, resonate, compelling, credible, clear, accurate, value story/scientific story/bedtime story.

Delivering a GVD:

Read zillions of papers like reading barcodes and do a systematic review in your head.
Understand the disease manifestations and diagnosis, epidemiology, clinical, economic and societal burden, the clinical data for the product and competitor products, policy and guidelines, unmet needs, therapeutic and economic landscape, market access strategy, and economic models.
Interpret a variety of study reports, which are often written by a statistician so require decoding, including systematic reviews, meta-analyses, indirect treatment comparisons, cost-effectiveness models, and budget impact models.
Weave into the scientific and economic narrative, the insights from the doctor/patient/payer advisory boards.
Write long and write short, and very short, and fast, and accurate, and create diagrams to explain or summarize, and process a stack of references, and structure a huge dossier for logical flow, and ensure consistency in editorial and graphical style.

Publications

I've written ~25 publications on HEOR & RWE, and presented on RWE publication writing at the 48th EMWA Conference in 2019.

HEOR & RWE publications overview:

Seasonal influenza burden of disease and cost-effectiveness of quadrivalent vaccine
Burden and costs of Clostridium difficile
Primary and secondary care resource use and medical costs of acute respiratory illness
Healthcare use and direct costs of otitis media
Burden and costs of RSV in children and the cost-effectivess of vaccination
Observational study of malaria chemoprophylaxis in travellers
Surgical registry studies of percutaneous nephrolithotomy
Seasonal influenza test-negative case-control studies of hospital outcomes
Survey of travellers about perceptions of rabies risk
Self-controlled case series of pandemic influenza vaccine in organ transplant recipients
Uptake of influenza, pneumococcal, Tdap, and herpes zoster vaccines
Vaccine coverage of tetanus, diphtheria, and acellular pertussis
Modelling influenza vaccine immunogenicity
Retrospective cohort study of pneumococcal conjugate vaccines in otitis media
Observational study of kidney transplant patients in clinical practice
Healthcare resource use for mental health in bowel disease
Incidence, coverage, and effectiveness of pertussis vaccination

Moon Medical Communications Ltd

Registered office: Seacourt Tower, West Way, Oxford, Oxfordshire, OX2 0FB

Registered no.: 7363475 (England & Wales)